About
Our Science
News & Media
Careers
Contact Us
Urinary Cancer Test
JP
/
EN
About
Vision, Mission, and Values
Message from the CEO
Corporate Overview
Leadership Team
Company Name & Logo
Access / Location
Our Science
Cancer Detection
SMA/SCID
Bio-AI
Clinical Studies
Publications
News & Media
All
Press
Research
Media
Award
News
Careers
Contact Us
News & Media
All
→
Press
→
Research
→
Media
→
Award
→
News
All
Research
Craif’s Urinary MicroRNA Study Demonstrates Early Detection, Prognostic Stratification, and Lung Cancer Recurrence Monitoring, Published in
npj Precision Oncology
2026.04.30
Research
Craif Presents Collaborative Research on Urinary MicroRNA-Based Early Detection and Prognostic Stratification in Lung Cancer at the AACR Annual Meeting 2026
2026.04.30
Press
Craif Opens Bio-AI Laboratory in San Diego, U.S.
2026.04.23
Press
Craif Appoints Takeo Mukai as CFO Through Local U.S. Hire ~ Driving Non-Linear Growth of Craif's Global Business with Extensive Experience Leading Exits as CEO/COO/CFO Across Multiple U.S. Healthcare Companies ~
2026.04.23
Press
Craif Establishes U.S. Business Office in San Diego – Selected to Join Johnson & Johnson’s JLABS San Diego –
2025.10.15
Press
Craif Raises US＄22 million in Series C Funding, Accelerates U.S. Expansion and R&D
2025.04.27
Research
Craif selected for Medtech Innovator 2024 Cohort,the world's largest medtech accelerator
2024.06.09
Research
Craif Scientific Advisor and Co-founder Yasui's research findings on ovarian cancer were published in Nature Communications
2023.11.07
News
The Number of Medical Institution Installing miSignal® Achieved 300
2023.03.22
Press
Craif Announced New Product in miSignal® Series, “Remote Cancer TestTM”
2022.10.31
1
2
3
4
5
Last
News & Media
All
→
Press
→
Research
→
Media
→
Award
→
News
